🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 24823R105
- Market Cap
- Large Cap · $2 Billion
- IPO
- 12/8/2017 · $18.00/share
Business: Denali Therapeutics, Inc. is a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases.
Company Contact
- CEO
- Ryan J. Watts
- CFO
- Steve E. Krognes
- Headquarters
- 151 Oyster Point Blvd., 2nd Floor South San Francisco, CA 94080
- Phone
- 650-866-8548
- Investor Relations
- Lizzie Hyland, Glover Park Group · 646-495-2706 · lhyland@gpg.com